Predictive value of ATP7b, BRCA1, BRCA2, PARP1, RAP80, HOXA9, DAXX, ERCC1, thioredoxin-1, TSP1, and TXR1 genes in patients with epithelial ovarian cancer (EOC) WHO received platinum-taxane first line therapy.

Predictive Value ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Thioredoxin 1 ◽

Brca1 Brca2

Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy

The Pharmacogenomics Journal ◽

10.1038/tpj.2016.63 ◽

2016 ◽

Vol 17 (6) ◽

pp. 506-514 ◽

Cited By ~ 5

Author(s):

S Pontikakis ◽

C Papadaki ◽

M Tzardi ◽

M Trypaki ◽

M Sfakianaki ◽

...

Keyword(s):

Ovarian Cancer ◽

Predictive Value ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Brca1 Brca2

Use of OvaRex(r) MAb-b43.13 as an immunotherapeutic treatment of epithelial ovarian cancer: experience as single agent post first-line therapy and in combination with chemotherapy in recurrent disease

European Journal of Cancer ◽

10.1016/s0959-8049(02)81106-6 ◽

2002 ◽

Vol 38 ◽

pp. S137

Keyword(s):

Ovarian Cancer ◽

Recurrent Disease ◽

Single Agent ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Cancer Experience

COMPARISON OF IFOSFAMIDE VERSUS CYCLOPHOSPHAMIDE IN COMBINATION WITH CISPLATIN AND DOXORUBICIN (ADRIAMYCIN), AS FIRST-LINE THERAPY FOR ADVANCED EPITHELIAL OVARIAN-CANCER - REPORT OF A PILOT-STUDY

Oncology Reports ◽

10.3892/or.1.3.631 ◽

1994 ◽

Author(s):

RE HEMPLING ◽

MS PIVER ◽

TR BAKER ◽

AM STANTON ◽

DL DRISCOLL

Keyword(s):

Ovarian Cancer ◽

Pilot Study ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Secondary cytoreductive surgery in epithelial ovarian cancer: Nonresponders to first-line therapy

Gynecologic Oncology ◽

10.1016/0090-8258(89)90593-3 ◽

1989 ◽

Vol 33 (1) ◽

pp. 1-5 ◽

Cited By ~ 63

Author(s):

Mitchell Morris ◽

David M. Gershenson ◽

J.Taylor Wharton

Keyword(s):

Ovarian Cancer ◽

Cytoreductive Surgery ◽

First Line ◽

First Line Therapy ◽

Secondary Cytoreductive Surgery ◽

Line Therapy

Continuous infusion of ifosfamide and cisplatin as first-line therapy of patients with suboptimally debulked stage III-IV epithelial ovarian cancer

International Journal of Gynecological Cancer ◽

10.1046/j.1525-1438.1998.97110.x ◽

1998 ◽

Vol 8 (2) ◽

pp. 138-143 ◽

Cited By ~ 2

Author(s):

Malik ◽

Khan ◽

Hussain ◽

Moid ◽

...

Keyword(s):

Ovarian Cancer ◽

Continuous Infusion ◽

Stage Iii ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.03.017 ◽

2006 ◽

Vol 103 (2) ◽

pp. 439-445 ◽

Cited By ~ 8

Author(s):

C.B. Steer ◽

K. Chrystal ◽

K.A. Cheong ◽

E. Galani ◽

G.M. Marx ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.5034 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5034-5034 ◽

Cited By ~ 1

Author(s):

K. Chrystal ◽

C. B. Steer ◽

K. A. Cheong ◽

E. Galani ◽

A. Strickland ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Secondary cytoreductive surgery in epithelial ovarian cancer: Nonresponders to first-line therapy

International Journal of Gynecology & Obstetrics ◽

10.1016/0020-7292(89)90348-2 ◽

1989 ◽

Vol 30 (2) ◽

pp. 196-196

Author(s):

M Morris ◽

DM Gershenson ◽

JT Wharton

Keyword(s):

Ovarian Cancer ◽

Cytoreductive Surgery ◽

First Line ◽

First Line Therapy ◽

Secondary Cytoreductive Surgery ◽

Line Therapy

Weekly paclitaxel and carboplatin followed by topotecan (TC-TP), as first-line therapy for patients with advanced epithelial ovarian cancer (AOC) suboptimally debulked. Updated preliminary results

European Journal of Cancer ◽

10.1016/s0959-8049(01)81458-1 ◽

2001 ◽

Vol 37 ◽

pp. S260-S261

Author(s):

J.A. Arranz Arija ◽

R. Gonzalez-Beca ◽

A. Velasco ◽

M.M. Perez ◽

P. Borrega ◽

...

Keyword(s):

Ovarian Cancer ◽

Weekly Paclitaxel ◽

First Line ◽

Preliminary Results ◽

First Line Therapy ◽

Line Therapy ◽

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.5034 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5034-5034

Author(s):

K. Chrystal ◽

C. B. Steer ◽

K. A. Cheong ◽

E. Galani ◽

A. Strickland ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽